IGEA Pharma NV | Elevator Pitch | Vincenzo Moccia, CEO / Antonello Sannia, Scientific Chief
Share

Chapters

00:09 Introduction

00:16 Company Overview – Vincenzo Moccia, CEO

04:14 Products – Antonello Sannia, Scientific Chief

Attachments

Igea Pharma NV

Siriusdreef, 17

2132 WT, Hoofddorp

Netherlands

 

Phone: +31 23 568 91 00

Company Profile

IGEA Pharma NV (IGEA) is a Holding Company listed on the SIX Zurich Swiss Exchange with Headquarters in the Netherlands.

 

IGEA has recently completed a business combination with Blue Sky Natural Resources Ltd (BSNR).

 

IGEA is a life sciences business and offers medical testing devices and dietary supplements. The company’s focus is on products and services related to the prevention of Alzheimer’s disease and Diabetes Type II.

 

BSNR is a UK based holding company which has a 50% equity interest in Blue Sky Swisse SA (BSS), a company developing a supercritical CO2 extraction business for the CBD market serving the wellness, food & beverage and nutraceutical industries.

 

On April 28th the Igea extraordinary general meeting approved the resolution of the Board to enter the business combination with BSNR. On the 29th of June Igea BOD resolved to launch the offer to BSNR and issue up to a maximum of 309’600’000 new shares (with an exchange ratio 1:9) reserved for allotment to the shareholders of BSNR in exchange for the contribution in-kind of their shares of BSNR.

 

On July 9th the GSM of Igea resolved to change the name of the combined entity to “IGEA Pharma NV”

 

The transaction was effective on 23rd September 2021

Featuring

Vincenzo Moccia
CEO | Igea Pharma NV AG
Antonello Sannia
Scientific Chief | Igea Pharma NV AG

More Elevator Pitches

More Presentations

Reviews for

IGEA Pharma NV | Elevator Pitch | Vincenzo Moccia, CEO / Antonello Sannia, Scientific Chief
There are currently no reviews for
IGEA Pharma NV | Elevator Pitch | Vincenzo Moccia, CEO / Antonello Sannia, Scientific Chief
Scroll to top